XML 9 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 11,920 $ 7,091
Trade receivables 11,292 11,259
Amounts due from joint venture 10,873 411
Other receivables 332 1,571
Inventories (note 5) 22,485 17,309
Prepaid expenses and deposits 889 810
Biological asset (note 6) 4,230 4,405
Total current assets 62,021 42,856
Non-current assets    
Property, plant and equipment (note 7) 77,479 81,754
Investment in joint venture (note 8) 18,108 15,727
Other assets (note 9) 2,207 2,004
Total assets 159,815 142,341
Current liabilities    
Line of credit 2,000  
Trade payables 14,601 12,952
Current maturities of long-term debt (note 10) 3,414 2,620
Accrued liabilities 3,509 3,793
Current maturities of capital lease obligations 78 72
Total current liabilities 23,602 19,437
Non-current liabilities    
Long-term debt (note 10) 32,445 35,760
Deferred tax liability (note 16) 1,920 4,825
Other liabilities 1,050 1,097
Capital lease obligations 102 179
Total liabilities 59,119 61,298
SHAREHOLDERS' EQUITY    
Share capital (note 20) 60,872 36,115
Contributed surplus 2,198 1,726
Revaluation surplus (note 7) 4,321 4,321
Accumulated other comprehensive loss (562) (391)
Retained earnings 33,867 39,272
Total shareholders' equity 100,696 81,043
Total liabilities and shareholders' equity $ 159,815 $ 142,341